SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-18-032207
Filing Date
2018-07-12
Accepted
2018-07-11 21:36:31
Documents
4
Period of Report
2018-07-11
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8k.htm 8-K 17465
2 EXHIBIT 99.1 ex99_1.htm EX-99.1 31917
3 image0.jpg GRAPHIC 84627
4 image1.jpg GRAPHIC 9242
  Complete submission text file 0001140361-18-032207.txt   179960
Mailing Address 2855 GAZELLE CT CARLSBAD CA 92010
Business Address 55 CAMBRIDGE PARKWAY SUITE 100 CAMBRIDGE MA 02142 760-603-2732
AKCEA THERAPEUTICS, INC. (Filer) CIK: 0001662524 (see all company filings)

IRS No.: 472608175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38137 | Film No.: 18949542
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1